LOGIN  |  REGISTER
Astria Therapeutics
Assertio

RxSight to Feature Live Learning Sessions at American Academy of Ophthalmology 2025 Annual Meeting

October 16, 2025 | Last Trade: US$8.95 0.55 -5.79

ALISO VIEJO, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) --  RxSight, Inc. (Nasdaq: RXST), an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced it will be featured in multiple Live Learning Sessions at Booth #2931 during the American Academy of Ophthalmology Annual Meeting (AAO 2025), taking place October 18–20 at the Orange County Convention Center in Orlando, Fla.

This year’s Live Learning Sessions showcase real-world insights from leading surgeons who have incorporated the Light Adjustable Lens into their practices, highlighting the clinical advantages and the economic impact of adjustability.

LIVE LEARNING SESSIONS – RxSight Booth #2931

Saturday, October 18

10:00 AMROI You Can See with the Light Adjustable Lens
Taylor Strange, DO and Kasey Gantz – Alliance Vision Institute, Texas

11:00 AMJump Starting My Career with the Light Adjustable Lens
Brian Szabo, DO – Newsom Eye, Florida

12:00 PMLocking in Clinical Confidence with the Light Adjustable Lens
Tanner Ferguson, MD – Vance Thompson Vision, South Dakota

1:00 PMAccelerating Premium Lens Adoption with the Light Adjustable Lens
Matt Kaufman, MD – Eye Health Northwest, Oregon

2:00 PMWho Really Benefits from the Light Adjustable Lens?
Eva Kim, MD – ICON Eyecare, Colorado

3:00 PMDiscovering Versatility with the Light Adjustable Lens
Quentin Allen, MD – Florida Vision Institute, Florida

Sunday, October 19

10:00 AMStarting Strong with the Light Adjustable Lens
Alison Early, MD – Signature Cataract & Laser Consultants, Ohio

11:00 AMSeeing Outcomes in a New Light with the Light Adjustable Lens
John Doane, MD – Discover Vision Centers, Kansas

12:00 PMThe Right Words for the Right Light Adjustable Lens Experience
Thomas Meirick, MD – Wolfe Eye Clinic, Iowa

1:00 PMThe Power of Adjustability: Patient-Centered Outcomes with the Light Adjustable Lens
John Josephson, MD – Eye Specialists and Surgeons of Northern Virginia, Virginia

About RxSight, Inc.

RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®/LAL+®, collectively the “LAL”), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.

Company Contact:
Shelley B. Thunen
Chief Financial Officer
This email address is being protected from spambots. You need JavaScript enabled to view it.

Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
This email address is being protected from spambots. You need JavaScript enabled to view it.

Stock Quote

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page